Fusion Antibodies: Pharma firm has ‘challenging’ year despite strong sales pipeline September 5, 2024 Pharmaceutical company Fusion Antibodies said it had a “challenging” year but has seen its sales pipeline grow. Fusion posted audited revenue of £1.14m for the year ended March 2024, a 60 per cent drop from the £2.9m it reported in 2023. The company, which specialises in antibody discovery, engineering and supply for therapeutic drugs, said [...]
Jet2 welcomes ‘booking momentum’ as it doubles down on package holidays September 5, 2024 Budget airline and leisure group Jet2 has welcomed a late bout of” booking momentum” in July and August, and doubled down on its strategy to ramp up its package holiday offering. The Aim-listed carrier, which in July hiked its dividend after reporting record passenger numbers, said it had maintained its momentum throughout late summer in [...]
Chapel Down: Half-year profit almost wiped out as wine maker blames ‘one-off factors’ September 4, 2024 English wine producer Chapel Down has blamed ‘one-off factors’ for its pre-tax profit almost being wiped out during the first half of its financial year. The Kent-headquartered company, which is listed on AIM, said the fall from £2.4m to £40,000 in the in the six months ended 30 June was due to a ‘difficult macroeconomic environment’, [...]
Midwich: Tech distributor posts solid growth despite headwinds September 3, 2024 Audio and TV distributor Midwich has defied broader market headwinds to post a double-digit rise in gross profit and improved revenue numbers. The Norfolk-based firm, which has been a constituent of London’s Aim market since 2016, grew by 7.5 per cent at constant currency in the six months to June 30, raking in £446m in [...]
Getbusy: Productivity software firm’s shares sink as growth slows September 3, 2024 Shares in productivity software provider Getbusy plunged nearly 11 per cent on Tuesday morning after it disappointed investors with its half-year results. Annual recurring revenue (ARR) grew less than £1m in the first six months of 2024 to £21m and net cash tumbled to £0.2m, down from £1.7 last year, which Getbusy said reflected “a [...]
Ashtead Technology posts ‘record’ half year as it eyes more deals September 2, 2024 Ashtead Technology said it achieved a “record” performance in the first half of the year as it looks to build out its merger and acquisition (M&A) pipeline. In the six months ended 30 June 2024, the subsea equipment rental and provider for the offshore energy industry posted a 61 per cent year-on-year increase in revenue [...]
Biotech firm Reneuron becomes latest to quit AIM as it battles for survival August 30, 2024 Biotech firm Reneuron Group has become the latest company to exit from the London Stock Exchange’s AIM as it continues to fight for its life after entering administration. The Welsh company, which was first floated on London’s junior market in 2005, said it did not believe it would be able to raise enough funds to [...]
Frenkel Topping warns of lower earnings in second half August 29, 2024 Frenkel Topping, the specialist professional services firm, has reported a rise in revenue in the first half of the year but warned that earnings are trading behind management’s expectations. In the six months ended 30 June 2024, Frenkel Topping posted £17.9m in revenue, a 12 per cent increase on the previous year’s £16m. Its gross profit also jumped five [...]
Octopus quietly pumps £25m into ‘mispriced’ AIM market August 29, 2024 Octopus Group has quietly pumped £25m of its own cash into London’s beleaguered AIM market in a bid to take advantage of “mispriced” smaller companies, it has been revealed.
Cambria Africa eyes AIM delisting as it plots liquidation of assets August 27, 2024 Cambria Africa, a holding company with investments in Zimbabwe, has announced plans to delist its shares from London’s AIM market. The company’s shares have been suspended from trading since March following its failure to release its financial results for the year ending August 2023 and for the six months ending February 2024. The long-awaited financial [...]